4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001159036-26-000149
Director sold 5,000 shares at an average $96.43 ($482,147)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Posard Matthew L. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-18 | Sale : show line 1 in the form 10b5-1 | −3,400 | $96.17 | $326,988 | 50,209 | D |
| 2026-11-18 | Sale : show line 2 in the form 10b5-1 | −1,600 | $96.97 | $155,158 | 48,609 | D |
| Open-market sales · 5,000 sh · avg $96.43 · $482,147 | ||||||
Loading xslF345X06/wk-form4_1795045684.xml…